The antidepressant-like effects of Danzhi Xiaoyao San and its active ingredients

被引:9
作者
Xie, Zhiqiang [1 ,2 ]
Xie, Hongxiao [1 ,2 ]
Peng, Xi [1 ,2 ]
Hu, Jingwen [1 ,2 ]
Chen, Li [1 ,3 ,4 ]
Li, Xiangyu [1 ,2 ]
Qi, Hu [1 ,2 ]
Zeng, Jiuseng [1 ,2 ]
Zeng, Nan [1 ,2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Sichuan, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu 611137, Sichuan, Peoples R China
[3] Chengdu Med Coll, Clin Med Coll, Dept Pharm, Chengdu, Peoples R China
[4] Chengdu Med Coll, Affiliated Hosp 1, Chengdu 610500, Peoples R China
关键词
Danzhi Xiaoyao San; Depression; Neuroinflammation; HPA axis; Neuroplasticity; Active ingredients; DEPRESSIVE-LIKE BEHAVIOR; HPA AXIS; STRESS; DISORDERS; SEROTONIN; CORTISOL; MODEL; PATHOPHYSIOLOGY; NEUROPLASTICITY; PHARMACOLOGY;
D O I
10.1016/j.phymed.2023.155015
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Depression is a severe mental illness that endangers human health. Depressed individuals are prone to sleep less and to the loss of appetite for food; their thinking and cognition processes, as well as mood, may even be affected. Danzhi Xiaoyao San (DXS), documented in the Internal Medicine Summary, has been used for hundreds of years in China and is widely applied traditionally to treat liver qi stagnation, liver and spleen blood deficiency, menstrual disorders, and spontaneous and night sweating. DXS can also clear heat and drain the liver. Presently, it is used frequently in the treatment of depression based on its ability to clear the liver and alleviate depression. Purpose: To summarize clinical and preclinical studies on the antidepressant-like effects of DXS, understand the material basis and mechanisms of these effects, and offer new suggestions and methods for the clinical treatment of depression. Methods: "Danzhi Xiaoyao", "Danzhixiaoyao", "Xiaoyao", "depression" and active ingredients were entered as keywords in PubMed, Google Scholar, CNKI and WANFANG DATA databases in the search for material on DXS and its active ingredients. The PRISMA guidelines were followed in this review process. Results: Per clinical reports, DXS has a therapeutic effect on patients with depression but few side effects. DXS and its active ingredients allegedly produce their neuroprotective antidepressant-like effects by modulating monoamine neurotransmitter levels, inhibiting the hypothalamic-pituitary-adrenal (HPA) axis hyperfunction, reducing neuroinflammation and increasing neurotrophic factors. Conclusion: Overall, DXS influences multiple potential mechanisms to exert its antidepressant-like effects thanks to its multicomponent character. Because depression is not caused by a single mechanism, probing the antidepressant-like effects of DXS could further help understand the pathogenesis of depression and discover new antidepressant drugs.
引用
收藏
页数:18
相关论文
共 132 条
[1]  
[Anonymous], 2017, Guangming J. Chinese Med.
[2]  
Bai J.C., 2016, Asia-Pacific Tradition. Medi, V12, P24
[3]   The Expanded Biology of Serotonin [J].
Berger, Miles ;
Gray, John A. ;
Roth, Bryan L. .
ANNUAL REVIEW OF MEDICINE, 2009, 60 :355-366
[4]   The Bidirectional Relationship of Depression and Inflammation: Double Trouble [J].
Beurel, Eleonore ;
Toups, Marisa ;
Nemeroff, Charles B. .
NEURON, 2020, 107 (02) :234-256
[5]   Serotonin and beyond: therapeutics for major depression [J].
Blier, Pierre ;
El Mansari, Mostafa .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2013, 368 (1615)
[6]   Neural basis of major depressive disorder: Beyond monoamine hypothesis [J].
Boku, Shuken ;
Nakagawa, Shin ;
Toda, Hiroyuki ;
Hishimoto, Akitoyo .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (01) :3-12
[7]   Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis [J].
Cai, Li ;
Li, Rong ;
Tang, Wen-jian ;
Meng, Gang ;
Hu, Xiang-yang ;
Wu, Ting-ni .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (08) :1332-1341
[8]   Astrocyte-derived ATP modulates depressive-like behaviors [J].
Cao, Xiong ;
Li, Liang-Ping ;
Wang, Qian ;
Wu, Qiong ;
Hu, Hong-Hai ;
Zhang, Meng ;
Fang, Ying-Ying ;
Zhang, Jie ;
Li, Shu-Ji ;
Xiong, Wen-Chao ;
Yan, Hua-Cheng ;
Gao, Yu-Bo ;
Liu, Ji-Hong ;
Li, Xiao-Wen ;
Sun, Li-Rong ;
Zeng, Yuan-Ning ;
Zhu, Xin-Hong ;
Gao, Tian-Ming .
NATURE MEDICINE, 2013, 19 (06) :773-+
[9]   A protocol of randomized controlled trial for Modified Xiaoyao Powder in the treatment of chronic obstructive pulmonary disease combined mild to moderate depression [J].
Chen, Keling ;
Zhao, Keni ;
Wang, Wujun ;
Xiao, Wei ;
Xiao, Jing ;
Yang, Yang ;
Liu, Yufei ;
Xie, Xiaohong .
MEDICINE, 2020, 99 (47) :E23220
[10]   Involvement of FGF-2 modulation in the antidepressant-like effects of liquiritin in mice [J].
Chen, Min ;
Zhang, Qiu-Ping ;
Zhu, Ji-Xiao ;
Cheng, Jie ;
Liu, Qing ;
Xu, Guang-Hui ;
Li, Cheng-Fu ;
Yi, Li-Tao .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881